Eagle Pharmaceuticals
EGRX
#11130
Rank
โ‚ฌ2.98 M
Marketcap
0,23ย โ‚ฌ
Share price
0.00%
Change (1 day)
-78.96%
Change (1 year)

Eagle Pharmaceuticals (EGRX) - Total liabilities

Total liabilities on the balance sheet as of June 2023 : โ‚ฌ0.13 Billion

According to Eagle Pharmaceuticals 's latest financial reports the company's total liabilities are โ‚ฌ0.13 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Eagle Pharmaceuticals - Total liabilities on balance sheet (from 2013 to 2023)

Total liabilities by year

Year Total liabilities Change
2022-12-31โ‚ฌ0.16 B135.8%
2021-12-31โ‚ฌ68.23 M24.94%
2020-12-31โ‚ฌ54.61 M-18.83%
2019-12-31โ‚ฌ67.28 M-1.11%
2018-12-31โ‚ฌ68.04 M-10.2%
2017-12-31โ‚ฌ75.77 M26.32%
2016-12-31โ‚ฌ59.98 M91.43%
2015-12-31โ‚ฌ31.33 M
2014-09-30โ‚ฌ16.08 M35.57%
2013-09-30โ‚ฌ11.86 M-29.42%
2012-09-30โ‚ฌ16.81 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ105.25 B 75,757.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ72.27 B 51,990.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
โ‚ฌ97.90 B 70,458.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ76.24 B 54,848.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ59.36 B 42,685.14%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚ฌ64.25 B 46,206.57%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚ฌ29.15 B 20,910.33%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel